1007308-75-9 Usage
Uses
Used in Pharmaceutical Industry:
2,4-dichloro-7-fluoro-6-nitroquinazoline is used as a building block for the synthesis of new drugs, leveraging its unique structure and properties to contribute to the development of innovative medicinal compounds.
Used in Medicinal Chemistry Research:
2,4-dichloro-7-fluoro-6-nitroquinazoline serves as a molecular probe, facilitating the study of various biological processes and mechanisms, which is crucial for advancing our understanding of disease pathways and potential therapeutic targets.
Used in Anti-Tumor Applications:
2,4-dichloro-7-fluoro-6-nitroquinazoline is used as a potential anti-tumor agent, indicating its capacity to target and combat cancer cells, making it a subject of interest for further research into its efficacy and mechanisms of action against tumors.
Used in Anti-Microbial Applications:
2,4-dichloro-7-fluoro-6-nitroquinazoline is also considered for its potential as an anti-microbial agent, suggesting that it may have the ability to inhibit or kill microorganisms, which could be significant in the development of new antibiotics or antifungal agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1007308-75-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,3,0 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1007308-75:
(9*1)+(8*0)+(7*0)+(6*7)+(5*3)+(4*0)+(3*8)+(2*7)+(1*5)=109
109 % 10 = 9
So 1007308-75-9 is a valid CAS Registry Number.
1007308-75-9Relevant academic research and scientific papers
QUINAZOLINE DERIVATIVE AS PHOSPHODIESTERASE INHIBITOR AND A PROCESS FOR PREPARING THE SAME
-
, (2010/11/30)
The present invention relates to a quinazoline derivative, a preparation method thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, a hydrate thereof, a pharmaceutical composition comprising the same and use thereof as a therapeutic agent. The present inveniont relates to a quinazoline derivative exhibiting inhibitory activity against C
